Michael S. Poirier Qualigen Therapeutics, Inc. (QLGN) insider trading activity

QLGN Quotes by TradingView

Michael S. Poirier is Chairman and CEO of Qualigen Therapeutics, Inc.. Currently has a direct ownership of 199,202 shares of QLGN, which is worth approximately $804,776. The most recent transaction as insider was on Jun 22, 2022, when has been sold 30,000 shares (Common Stock) at a price of $0.57 per share, resulting in proceeds of $17,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 199K
0% 3M change
0% 12M change
Total Value Held $804,776

Michael S. Poirier Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 22 2022
BUY
Open market or private purchase
$17,100 $0.57 p/Share
30,000 Added 13.09%
199,202 Common Stock
MSP

Michael S. Poirier

Chairman and CEO
Carlsbad, CA

Track Institutional and Insider Activities on QLGN

Follow Qualigen Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QLGN shares.

Notify only if

Insider Trading

Get notified when an Qualigen Therapeutics, Inc. insider buys or sells QLGN shares.

Notify only if

News

Receive news related to Qualigen Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on QLGN